Friday, August 16, 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $TGOD.TO) (CSE: $DIXI.U.C) (OTCQX: $DXBRF) (TSX: $TRST.TO) (NYSE: $CTST) (TSX: $WEED.TO) (NYSE: $CGC)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $TGOD.TO) (CSE: $DIXI.U.C) (OTCQX: $DXBRF) (TSX: $TRST.TO) (NYSE: $CTST) (TSX: $WEED.TO) (NYSE: $CGC)



Delta, Kelowna, BC –August 16, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), announced that it has completed its inaugural shipment to the Ontario Cannabis Store, marking the Company's entrance into Canada's recreational market. Ontario consumers will soon be able to experience TGOD's acclaimed Unite Organic dried flower, the Company's high THC signature strain, which will be available on www.ocs.ca as well as at select retail locations across the province.
"We are thrilled to introduce Unite Organic dried flower to Ontario adult consumers. Launched earlier this year with our Grower's Circle, Unite Organic was highly praised by medical patients.  Our small pilot confirmed that market demand for premium certified organic cannabis exceeds available supply," commented Brian Athaide, CEO of TGOD.  "Today's milestone gets us one step closer to achieving our vision of becoming the world's leading brand for premium certified organic cannabis in both medical and recreational segments.  We look forward to continuing to expand our distribution network as we ramp up production in the months ahead."      
In a recent study conducted by Hill & Knowlton, over 50% of recreational consumers stated that it is important that their cannabis be organic. TGOD's cannabis is grown in the Company's proprietary living soil, in accordance with all-natural principles and without irradiation. The Company's growing process is also certified organic by both Pro-cert and ECOCERT, two leading organic certification bodies, providing consumers with a safe, consistent, and enjoyable cannabis experience.   
Initially available to a small group of medical patients called the Grower's Circle, TGOD recently opened sales to medical patients across the country. The Company has also signed supply agreements with Alberta and British Columbia.

Dixie Brands Inc. (CSE: DIXI.U) (OTCQX: DXBRFtoday announced a number of new product and marketing initiatives from its pet wellness subsidiary, Therabis LLC.
Therabis, a research-driven pioneer in the broad-spectrum hemp-based pet supplement market, continued its heritage of vet-inspired innovation at SuperZoo 2019, the preeminent national show for pet retailers, announcing the launch of its new Mobility soft chews for dogs. Designed to promote joint health and a healthy inflammatory system in dogs, the new soft chew also showcases the new brand livery and updated packaging unveiled at the trade show and being rolled out across the Therabis portfolio.         
In addition to the new Mobility soft chews, Therabis recently introduced a new increased strength Veterinary Formula distributed through Vedco, the nation's largest distributor for vets. The formula features the brand's Mobility and Calming products with higher concentrations of naturally occurring cannabinoids and uses unique active ingredients to help support specific aspects of pet health. Therabis Veterinary Formula is now offered through veterinary hospitals and clinics across the country.   
Backed by 25 years of veterinary experience Dr. Stephen M. Katz founded Therabis with the goal of relieving some of the most common pet ailments with the proven benefits of natural ingredients. Each Therabis product is formulated with only the best nutritionally rich and naturally derived ingredients. The broad-spectrum hemp-infused supplements combine naturally occurring cannabidiol, green-lipped mussel and specific vitamins and minerals, like vitamin C and chromium for dogs and L-Taurine for cats. These fast-acting, powerful supplements are easy to administer and target specific conditions including joint mobility, anxiety and skin irritation.
"Throughout the years, Therabis continues to receive wonderful responses about our indication-specific formulas from satisfied consumers sharing their heart-warming success stories about their pets' improved health," said Bob Rubin, President of Therabis. "Hearing this positive feedback from people who buy our products is so fulfilling – there's no better feeling than knowing we are making a difference in the lives of these animals and their owners."

CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTSTprovided an interim update on various matters.

Management Cease Trade Order
CannTrust announced that its application for a management cease trade order ("MCTO") under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203") has been approved by the Ontario Securities Commission ("OSC"). The MCTO does not affect the ability of investors who are not insiders to trade in the securities of the Company.
CannTrust announced on August 1, 2019 that it was filing an application seeking a MCTO from the OSC because the Company was likely to miss its filing deadline of August 14, 2019 to file an interim financial report for the three and six month periods ended June 30, 2019, an interim management's discussion and analysis for the corresponding period and certifications of interim filings (the "Q2 Financials").

The timing and content of CannTrust restoring any defaults in its Q2 Financials will depend, in large measure, upon the timing and impact of Health Canada's decisions regarding the Company's non-compliance with regulatory requirements. Although the Company, under the supervision of the Special Committee, is preparing a remediation plan for submission to, and consideration by Health Canada, Health Canada has advised the Company that it is unable to provide any guidance about the timing or content of its decisions concerning the Company.

The MCTO prohibits the directors and executive officers of the Company from trading in securities of the Company until two full business days after all filings CannTrust is required to make under Ontario securities laws are made, including filing of the Q2 Financials. The MCTO does not affect the ability of any other persons to trade in the securities of the Company. CannTrust had already voluntarily imposed a blackout period on its directors and executive officers trading in the Company's securities.

The Company intends to satisfy the provisions of the alternative information guidelines in NP 12-203 by filing bi-weekly status reports in the form of news releases containing prescribed updating information until the Q2 Financials are filed.

New York Stock Exchange Discussions
The Company has been working pro-actively with the New York Stock Exchange ("NYSE") to keep the NYSE apprised of its interactions with Health Canada and related matters. Following a discussion on August 9, 2019 between representatives of the NYSE, the Company, the Company's counsel and counsel to the Company's special committee of independent directors (the "Special Committee"), the NYSE advised the Company that as a consequence of the Company's announcements concerning its audited financial statements for the year ended December 31, 2018 and its unaudited financial statements for the quarter ended March 31, 2019, the Company is viewed as no longer having a complete annual report on Form 40-F on file for the year ended December 31, 2018.

Trading of the Company's securities on the TSX and NYSE continues.  However, the NYSE advised the Company that (a) it will closely monitor the status of the Company's late filing and any related public disclosures for up to six months from its due date, and (b) if the Company fails to file its annual report and any subsequent reports within six months of their filing due dates, the NYSE will determine, in its sole discretion, whether to halt trading in the Company's securities or whether to allow the Company's securities to trade for up to an additional six months, depending upon the circumstances. If the NYSE determines that an additional six-month trading period is not appropriate, suspension and delisting procedures will commence pursuant to Section 804.00 of the NYSE's Listed Company Manual. Regardless of the procedures described above, the NYSE may commence delisting proceedings at any time during the period that is available to complete the filing, if circumstances warrant.

Interim Financial Update
As previously disclosed, the Company estimates the value of the inventory and biological assets impacted by the pending Health Canada decisions is approximately $51 million as at June 30, 2019. Management of the Company further estimates the impacted inventory represents approximately 53% of the Company's total inventory as at June 30, 2019 and the impacted biological assets represent approximately 30% of the Company's total biological assets as at June 30, 2019.

As at June 30, 2019, the Company had approximately $250 million in cash and cash equivalents.

Remediation Efforts

Under the supervision of the Special Committee, the Company is preparing a remediation plan for submission to and consideration by Health Canada.  Although the Special Committee is directing the Company to work closely with Health Canada to remediate the root causes of any non-compliance identified by Health Canada, to date the Company has not had any substantive discussions with Health Canada concerning remediation matters and Health Canada has advised the Company that it is currently unable to provide any guidance about the timing or content of its decisions concerning the Company.  As previously announced, Health Canada has placed a hold on inventory which includes approximately 5,200kg of dried cannabis that was harvested in the previously unlicensed rooms in Pelham, until it deems that the Company is compliant with regulations. In addition, CannTrust has instituted a voluntary hold of approximately 7,500kg of dried cannabis equivalent at its Vaughan manufacturing facility that was produced in the previously unlicensed rooms.  Health Canada has broad discretion to exercise a wide range of regulatory powers.  In the event that Health Canada orders the destruction of all or a substantial portion of the product grown in the previously unlicensed rooms, the Company's results for the second quarter of 2019 would be materially adversely impacted.  Health Canada has given no clear indication of what decisions it will come to with respect to the Company.

Lastly we look at Canopy Growth Corporation (TSX:WEED) (NYSE: CGC) who recently released their financial results for the first quarter ending June 30th, 2019.

According to Morningstar Equity Research director of basic materials Kristoffer Inton, “Shares for Canopy Growth now trade nearly 50% below our fair value estimate [$54 per share], as the lack of profitability continues to weigh on the market price. However, we think focusing on profitability this early in the company’s and industry’s evolution is misguided. Our confidence that profitability will come is bolstered by continued positive gross profit margins, as we think that overhead expense growth will moderate as the industry matures. We see the current share price as an attractive entry point for long-term investors.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  




Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories

No comments: